바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.83 No.3
Citation Share

Towards Understanding Tuberculosis- Related Issues in North Korea: A Narrative Review of North Korean Literature

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2020, v.83 no.3, pp.201-210
https://doi.org/10.4046/trd.2019.0070
Chang-Jun Lee (Yonsei University)
Sungwhan Lee (Yonsei University)
Hee Jin Kim (Korean National Tuberculosis Association)

Chang-Jun, L. , Sungwhan, L. , Hee, J. K. , & (2020). Towards Understanding Tuberculosis- Related Issues in North Korea: A Narrative Review of North Korean Literature. Tuberculosis & Respiratory Diseases, 83(3), 201-210, https://doi.org/10.4046/trd.2019.0070
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: North Korea is one of the 30 countries with the highest tuberculosis (TB) and drug-resistant TB burdened. To understand the medical issues and research trends associated with TB in North Korea, we performed a comprehensive review of articles related to clinical and laboratory research on TB published in North Korean medical journals. Methods: We reviewed all types of TB-related articles published in nine North Korean medical journals (Yebang ŭihak: Preventive medicine; Koryo ŭihak: Korea Medicine; Chosŏn ŭihak: Chosun Medicine; Naekwa: Internal Medicine; Soa, sanbuinkwa: Pediatrics, Obstetrics, and Gynecology, Surgery; Ŭihak: Medicine; Kich’o ŭihak: Basic Medicine; and Chosŏn yakhak: Chosun Pharmacy). We classified the articles according to the type and field of study and analyzed the data qualitatively to gain insights. Results: We reviewed 106 articles (one- or two-page length) written in Korean, including reviews (n=43), original articles (n=52), and case reports (n=8). They were classified as follows: articles on diagnosis (n=52, 49%) and treatment (n=39, 37%). None of the studies investigated the commercialized molecular diagnosis systems such as Xpert MTB/RIF. Directly Observed Treatment, Short-course was reported as the basic treatment approach. Furthermore, six studies used Korean traditional medicines for treating TB, with one of them containing snake venom. Conclusion: The articles were not sufficiently detailed. Original articles on the treatment of multi-drug resistant TB were not found, and those on latent tuberculosis infection and nontuberculous mycobacteria were limited. To understand the current medical issues associated with TB in North Korea, articles from these nine journals were not sufficient.

keywords
Tuberculosis, Democratic People's Republic of Korea, Review

Reference

1.

1. World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization; 2019.

2.

2. World Health Organization. Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance:Xpert MTB/RIF system. Geneva: World Health Organization;2011.

3.

3. Seung KJ, Linton SW. The growing problem of multidrug-resistant tuberculosis in North Korea. PLoS Med 2013;10:e1001486.

4.

4. Shin YJ, Ki M, Sung N. A new strategy for tuberculosis control in North Korea. Epidemiol Health 2015;37:e2015053.

5.

5. Burki T. North Korea and the global fund. Lancet Infect Dis 2018;18:501.

6.

6. Bahk J, Ezzati M, Khang YH. The life expectancy gap between North and South Korea from 1993 to 2008. Eur J Public Health 2018;28:830-5.

7.

7. Zastrow M. North and South Korea team up to tackle TB and malaria. Nature 2018 Nov 13 [Epub]. https://doi.org/10.1038/d41586-018-07393-y.

8.

8. Choi CM, June JH, Kang CI, Park JT, Oh SY, Lee JB, et al. Tuberculosis among dislocated North Koreans entering Republic of Korea since 1999. J Korean Med Sci 2007;22:963-7.

9.

9. Park DH, Choi MH, Lim AY, Shin HY. An analysis of infectious disease research trends in medical journals from North Korea. J Prev Med Public Health 2018;51:109-20.

10.

10. Ha S, Yoon SJ, Chun BC, Kim KJ, Roh SY, Lee EJ, et al. Bibliographical characteristics of North Korean medical journals and articles. J Korean Med Sci 2018;33:e185.

11.

11. World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis, WHO/HTM/TB/2008.402. Geneva: World Health Organization; 2008.

12.

12. Kim J, Kim D, Lee K. Study on the incidence of drug resistance according to the duration of DOTS drugs. Prev Med 2007;1:27.

13.

13. Hong ST. North Korean medical Journals in the Galapagos. J Korean Med Sci 2018;33:e209.

14.

14. World Health Organization. WHO treatment guidelines for drugresistant tuberculosis, WHO/HTM/TB/2016.04. Geneva:World Health Organization; 2016.

15.

15. Joint Monitoring Mission. Tuberculosis Control Programme Democratic People’s Republic of Korea. Geneva: Joint Monitoring Mission, World Health Organziation; 2017.

16.

16. Gee A. USA and North Korea work together on tuberculosis. Lancet 2010;375:1862.

17.

17. Parry J. North Korea’s fight against tuberculosis gets a boost. BMJ 2010;340:c2223.

18.

18. Stone R. North Korea. New tuberculosis lab hailed as breakthrough in health diplomacy. Science 2010;327:1312-3.

19.

19. Lee H, Ahn DY, Choi S, Kim Y, Choi H, Park SM. The role of major donors in health aid to the Democratic People’s Republic of Korea. J Prev Med Public Health 2013;46:118-26.

20.

20. Seung KJ, Franke M, Linton SW. Multidrug-resistant tuberculosis treatment in North Korea: is scale-up possible? PLoS Med 2016;13:e1002062.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy